Zinbryta Recall Lawyers: Worldwide Market Withdraw Due to Risk of Brain Inflammation
The new multiple sclerosis injection Zinbryta has been removed from the market worldwide, amid reports of encephalitis, meningoencephalitis and wrongful deaths linked to severe brain inflammation.
The drug recall lawyers at Saiontz & Kirk, P.A. are reviewing whether former users of this medication may be entitled to financial compensation through a Zinbryta lawsuit. To evaluate whether you or a loved one may have a case, request a free consultation and claim evaluation.
Zinbryta Side Effects
Zinbryta was approved by the FDA in 2016, for treatment of relapsing forms of multiple sclerosis. The injection drug was already the subject of a Risk Evaluation and Mitigation Strategy (REMS) program in the United States, due to concerns about liver side effects of Zinbryta. However, it does not appear that users or the medical community were adequately warned about the risk of brain inflammation on Zinbryta, or the importance of monitoring for symptoms like:
- Severe Headaches
- Nausea and Vomiting
- Persistent Fever
- Yellowing of the Skin or Eyes
The Zinbryta recall was announced in a press release issued by Biogen and AbVie on March 2, indicating that the drug makers were unable to properly characterize the brain inflammation risks associated with their drug given the limited number of individuals being treated. Therefore, the medication was voluntarily removed from the market worldwide.
An estimated 8,000 individuals have been treated with Zinbryta. However, an investigation by the European Medicines Agency announced this week indicated:
- At least 12 Zinbryta brain inflammation cases have been identified;
- Most problems occurred within 8 months of starting treatment;
- At least 3 deaths from Zinbryta were among the reports of inflammatory brain disorders reviewed;
- Individuals prescribed Zinbryta should not take another injection, and shuld contact their doctor to discuss treatment options;
- Regular blood tests should be continued for up to 6 months after stopping the drug to check for Zinbryta side effects
Zinbryta Brain Inflammation Lawsuits
For any users of the multiple sclerosis injection who have been diagnosed with encephalitis, meningoencephalitis or another brain inflammation problem on Zinbryta, financial compensation may be available due to the drug makers’ failure to properly research the side effects of the drug. Potential Zinbryta wrongful death lawsuits are also being evaluated for families of any individuals who may have died after use of the medication.
All cases are being evaluated for investigation purposes to determine what litigation options may be available. There are no out-of-pocket costs to contact our Zinbryta lawyers to evaluate a potential case, as we only receive an attorney fee or expenses if a recovery is obtained in your case.